Expand SYRE Menu
SYRE MENU

SYRE Stock Posts


SYRE #SpyreTherapeutics stock declines -1.5% in after hours trading. See the latest news.

After Hours Decliner

SYRE Spyre Therapeutics63.27+11.98+23.4%

After Hours:62.35-0.92 (-1.5%)

Spyre Therapeutics Announces Proposed Public Offering of its Common Stock

Globe NewswireMon, 13-Apr 4:46 PM

Unusual Option Volume

SYRE Spyre Therapeutics63.71+12.42 (+24.2%)

Spyre Therapeutics trades 3,300 contracts. The company has the following event: SPY001 Phase 2 SKYLINE Part A Data Webcast on Apr 13, 2026. News: Spyre Announces Potential Best-in-Class SPY001 Part A Induction Results from SKYLINE Trial in Moderate-to-Severe Ulcerative Colitis Patients
Unusual Option Volume

SYRE Spyre Therapeutics34.64+0.28 (+0.8%)

Spyre Therapeutics trades 2,117 contracts. The highest volume is in the 20-Mar-26 25 puts.
Unusual Option Volume

SYRE Spyre Therapeutics28.28-0.38 (-1.3%)

Spyre Therapeutics trades 2,129 contracts. The highest volume is in the 16-Jan-26 30 calls, which is 6.1% above the current price.
Unusual Option Volume

SYRE Spyre Therapeutics12.81-1.28 (-9.1%)

Spyre Therapeutics trades 6,000 contracts. The company has the following event: Digestive Disease Week (DDW) 2025 between May 3, 2025 and May 6, 2025.
Unusual Option Volume

SYRE Spyre Therapeutics14.67+0.45 (+3.2%)

Spyre Therapeutics trades 3,301 contracts. The highest volume is in the 20-Jun-25 15 calls, which is 2.2% above the current price.
Market Data Delayed 15 Minutes